![Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News](https://www.eubusinessnews.com/wp-content/themes/wp-bootstrap-starter/aigm-image-handler/handler.gz?src=https%3A%2F%2Fwww.eubusinessnews.com%2Fwp-content%2Fuploads%2F2022%2F10%2FBormioli-Pharma.jpg&width=654&height=auto&format=webp)
Bormioli Pharma and Pierre Fabre Develop a 100% Recycled PET packaging for ELUDRIL® Brand Mouthwashes - EU Business News
CONTROL study results show improved tolerability of NERLYNX® (neratinib) with all the investigated diarrhoea prophylaxis strategies | Pierre Fabre Pharma Norden AB
![Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - PR Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - PR](https://mma.prnasia.com/media2/1916090/Pierre_Fabre_Gennisium__Logo.jpg?p=medium600)
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets - PR
![Pierre Fabre's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile Pierre Fabre's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/pierre-fabre_owler_20160408_092926_original.jpg)